JOEL SAGET—AFP/Getty Images
Company Information
As of 8/3/2022
Country
France
Headquarters
Paris
Industry
Pharmaceuticals
CEO
Paul Hudson
Website
Company Type
Public
Ticker
SNY
Revenues ($M)
$46,317.9
Profits ($M)
$7,357.7
Market Value ($M)
$130,889
Employees
95,442
Figures prepared in accordance with International Accounting Standards. Market value as of July 19, 2022.
Key Financials (Last Fiscal Year)As of 8/3/2022
($ Millions)
% change
Revenues ($M)
$46,317.9
8.8%
Profits ($M)
$7,357.7
-47.6%
Assets ($M)
$136,715.2
-
Total Stockholder Equity ($M)
$78,090.3
-
Profit RatiosAs of 8/3/2022
Profit as % of Revenues
15.9%
Profits as % of Assets
5.4%
Profits as % of Stockholder Equity
9.4%
Sanofi Rank History
Historical Data
| Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
|---|---|---|---|---|
| 2021 | $42,580.11.1% | $14,031.2346.8% | $140,160.6 | $77,100.6 |
| 2020 | $42,119 | $3,140.6-38.2% | $126,534.9 | $66,147.5 |
| 2019 | $42,104.93.2% | $5,081.8-46.5% | $127,339.3 | $67,295.3 |
| 2018 | $40,810-1.4% | $9,506.982.6% | $119,867.9 | $69,751.4 |
| 2017 | $41,376-0.2% | $5,207.49.5% | $110,390 | $60,698 |
SHOW MORE
Lists ranking Sanofi
Latest news for Sanofi
- Health
Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billionJanuary 7, 2022, 1:58 PM UTC - Health
Its COVID-19 vaccine bogged down in trials, Sanofi to manufacture BioNTech/Pfizer dosesSeptember 10, 2021, 1:06 PM UTC
- Successful COVID-19 vaccines are just the first step to ending the pandemic;8:20Series, On Leading;
- Sanofi CEO on partnerships and timeline to find the coronavirus cure;7:05Digital Features;
- FORTUNE PREMIUMInsights: Sanofi, Accenture CEOs on How Humans and Machines Can Maximize Productivity;3:31Collections;
- Sanofi CEO on leadership: Remove obstacles, move faster, be decisive;4:39Series, On Leading;
